The transgene was designed with an N-terminal truncated form of human cyclin-dependent kinase 5, regulatory subunit 1 (CDK5R1 or p35) cDNA sequence, also referred to as p25, under the control of a tetracycline operator (tetO; also called tetracycline-responsive element (TRE, TetRE) or tet-operator). (J:131373)